In conclusion, we here demonstrate that VATS anatomical pulmonary resection is safe and feasible for central lung cancer, providing a low operative mortality and favorable outcomes in selected patients. Because of the short follow-up period, further case studies with long-term outcome data are necessary to verify our conclusions.